Cansortium Setting Up Shop in Casselberry, Growing Florida Footprint


Tony Deyes

April 17th, 2019

Exclusive, News, Top News


Cansortium (CSE: TIUM), one of Florida’s largest medical marijuana companies and the only one based in the state, with head offices in Miami, is once again expanding its retail presence with the addition of a Knox Medical dispensary in Casselberry, FL.

Cansortium controls one of 14 operating licenses in Florida – a state with the fastest growing medical cannabis patient population in the US – opened Orlando’s first dispensary in 2017. The company’s new location, 10 kilometres northeast of central Orlando, is designed to augment the Orlando dispensary and make it easier for residents in the north and eastern suburbs to obtain medical marijuana, whether in-store or through Knox’s delivery service.

Focus on Quality, Patient Satisfaction

While many of its competitors have saturated the Florida market, Cansortium has taken a far more measured, strategic approach and set itself apart by focusing on high standards and patient needs. Knox Medical dispensaries look more like pharmacies than the head shops which have sprung up throughout the state since the legalization of medical cannabis. Their locations are designed to be highly-visible, easily-accessible, convenient to shop at and get in & out of, and all are wheelchair-accessible. Their interiors are warm, professional, sleek and modern, staffed with knowledgeable salespeople who can guide patients through the process of selecting the right products and understand the importance of safeguarding patient privacy.

Until last month, Florida’s medical patients were limited to extract-based products, but a 2017 ban on the smoking of cannabis flower was finally overturned on March 19, 2019, meaning that as well as offering derivatives such as CBD/THC oils, vapes, tinctures, topical, etc. patients will now be able to obtain flower through Knox Medical, and the new law allows them to receive two and a half ounces of whole flower cannabis every 35 days.

Cansortium’s proprietary cultivation techniques give it an advantage over competitors relying solely on legacy cultivation practices. Its cultivation operations and R&D are overseen by a world-renowned PhD agronomist, and its proprietary drying & terpene extraction process requires only six hours per cycle, as opposed to the six days required using conventional methods, while preserving terpenes and whole plant profiles. The company currently operates a GMP-certified 31,000 sq ft greenhouse and 9,000 sq ft processing facility, with an additional 187,000 sq ft. of cultivation space being added in 2019.

Casselberry will be the tenth Florida Knox Medical dispensary, with an additional thirteen in development and seven more planned.

The Casselberry dispensary is scheduled to open April 12th, 2019 pending final inspection and Cansortium anticipates doing similar numbers to the existing Orlando facility.

The Bigger Picture

Cansortium also has retail, cultivation, and processing operations in Texas, Pennsylvania, Puerto Rico, as well as Colombia – the anticipated hub of the red hot emerging Latin American cannabis market. It’s recently expanded into Canada, the first federally-legalized recreational market in the world, and a domestic expansion into Michigan, where license-holders are allowed an unlimited number of dispensaries, is currently underway. The company is also engaged in strategic expansions into Argentina, Australia, and the emerging European market – which is expected to outpace the US and Canadian markets combined.

Cansortium has a proven record as a successful strategic first-mover in large markets with high barriers to entry, and its extensive regulatory expertise enables it to navigate the steadily-evolving medical cannabis regulatory framework, making it one to keep on your radar as the year progresses.

Keep watching this page, or visit http://cansortium.com/ for more information.

Disclaimer

The above article is sponsored content. Emerging Growth LLC, which owns CannabisFN.com and CFN Media, has been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: https://cannabisfn.com/legal-disclaimer/

 

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Tony Deyes



Network Partners

Follow Us on Social Media

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading